Abstract
Intermittent dialysis therapy is used in chronic uremia to re-establish body water solute concentrations that cannot be achieved by the natural organ. In this sense, the dialyzer becomes an artificial kidney and it is through the transport of substances by this device that chemical and biophysical control consistent with continued survival is achieved. The chapter is organized as shown in Figure 1 and will consist of two basic lines of development:
-
1.
Consideration of the dialyzer and its operating principles,
-
2.
Consideration of the patient-dialyzer system with regard to solute control in intermittent dialysis therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Michaels AS: Operating parameters and performance criteria for hemodialyzers and other membrane- separation devices. Trans Am Soc Artif Intern Organs 12: 387, 1966
Gotch FA, Autian J, Colton CK, Ginn HE, Lipps BJ, Lowrie EG: The Evaluation of Hemodialyzers. DHEW Publ no (NIH) 72–103: 7, 1971
Babb AL, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 17: 81, 1971
Klein E: Membranes and materials evaluation. Proc 7th Annual Contractors’ Conf. Artif Kidney- Chronic Uremia Program NIAMDD edited by Krueger KK, DHEW publ no (NIH) 75–248:85, 1974
Gotch FA, Sargent JA, Keen ML, Seid MA, Foster R: Comparative treatment time with Kiil, Gambro and Cordis-Dow Kidneys. Proc Clin Dial Transpl Forum 3: 217, 1973
Model FS, Davis HJ, Gordon MG: Prepare and evaluate optimized hemodialysis membranes. Proc 8th Annual Contractors Conf Artif Kidney — Chronic Uremia Program NIAMDD edited by Mackey BB, DHEW publ no (NIH) 76–248:71, 1975
Klein E, Lindholm DD, Smith JK, Holland FF: Study of synthetic polypeptides for hemodialysis membranes. Proc 7th Annual Contractors’ Conf Artif Kidney — Chronic Uremia Program NIAMDD edited by Krueger KK, DHEW publ no (NIH) 75–248:75, 1974
Barbour BH, Bernstein M, Cantor PA, Fisher BS, Stone W Jr: Clinical use of NISR 440 polycarbonate membrane for hemodialysis. Trans Am Soc Artif Intern Organs 21: 144, 1975
Wolf AV, Remp DG, Kiley JE, Currie GD: Artificial kidney function: Kinetics of Hemodialysis. J Clin Invest 30: 1062, 1951
Smith HW: The Kidney: Structure and Function in Health and Disease. New York, Oxford University Press, 1951, p 39
Gotch FA: Hemodialysis: Technique and kinetic considerations. Chapter 41 in The Kidney, edited by Brenner BM, Rector FC Jr, Philadelphia, WB Saunders Company, 1976, p 1673
Nolph KD, Nothum RJ, Mäher, JF: Effects of ultrafiltration on dialysance in commercially available coils. Kidney Int 2: 293, 1972
Nolph KD, Nothum RJ, Maher JF: Ultrafiltration: A mechanism for removal of intermediate molecular weight substances in coil dialyzers. Kidney Int 6: 55, 1974
Farrell PC, Babb AL: Estimation of the permeability of cellulosic membranes from solute dimensions and diffusivities.J Biomed Mater Res 7: 25, 1973
Bottomley S, Parsons FM, Broughton PMG: The dialysis of non-electrolytes through regenerated cellulose (Cuprophane). I. The effect of molecular size: J Appl Polym Sci 16: 2115, 1972
Babb AL, Farrell PC, Uvelli DA, Scribner BH: Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Intern Organs 18: 98, 1972
Popovich RP, Hlavinka DJ, Bomar JB, Moncrief JW, Decherd JF: The consequences of physiological resistances on metabolite removal from the patient — artificial kidney system. Trans Am Soc Artif Intern Organs 21: 108, 1975
French D: The Schardinger dextrins. Adv Carbohydrate Chem 12: 189, 1957
Horowitz HI: Uremic toxins and platelet function. Arch Intern Med 127–823, 1970
Cohen BD: Guanidinosuccinic acid in uremia. Arch Intern Med 126: 846, 1970
Giovannetti S, Biagini M, Cioni L: Evidence that methyl guanidine is retained in chronic renal failure. Experientia 24: 341, 1968
Schmidt EG, McElvain NS, Bowen JJ: Plasma amino acids and the ether soluble phenols in uremia. Am J Clin Path 20: 253, 1950
Gordon A, Bergström J, Fürst P, Zimmerman L: Separation and characterization of uremic metabolites in biologic fluids: A screening approach to the definition of uremic toxins. Kidney Int 7 (suppl): S45, 1975
Giovannetti S, Barsotti G: Dialysis of methylguanidine. Kidney Int 6: 177, 1974
Fürst P, Bergström J, Gordon A, Johnsson E, Zimmerman L: Separation of peptides of “middle” molecular weight from biological fluids of patients with uremia. Kidney Int 7 (suppl): S272, 1975
Funck-Brentano JL, Man NK, Sausse A, Zingraff J, Boudet J, Becker A, Cueille GF: Characterization of a 1100–1300 MW uremic neurotoxin. Trans Am Soc Artif Intern Organs 22: 163, 1976
Pitts RF: Physiology of the Kidney and Body Fluids. Chicago, Year Book Medical Publishers, Inc, 1968, p 181
Bartsch HJ: Handbook of Mathematical Formulas. Translated by Liebscher H, New York, Academic Press, 1974, p 139
Walser M, Bodenlos LJ: Urea metabolism in man. J Clin Invest 38: 1617, 1959
Lowrie EG, Steinberg SM, Galen MA, Gagneux SA, Lazarus JM, Gottlieb MN, Merrill JP: Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia. Kidney Int 10: 409, 1976
Kreyszig E: Advanced Engineering Mathematics New York, John Wiley and Sons, 1972, p 24, 147
Sokolnikoff IS, Redheffer RM: Mathematics of Physics and Modern Engineering. New York, McGraw Hill, 1958,p 23, 756
Giovannetti S, Maggiore Q: A low nitrogen diet with proteins of high biological value for severe chronic uremia. Lancet 1: 1000, 1964
Shaw AB, Bazzard FJ, Booth EM, Nilwarangkur S, Berlyne GM: The treatment of chronic renal failure by modified Giovannetti diet. QJ Med 34: 237, 1965
Kerr DNR, Robson A, Elliott RW, Ashcroft R: Diet in chronic renal failure. Proc Roy Soc Med 60: 115, 1967
Franklin SS, Gordon A, Kleeman CR, Maxwell MH: Use of a balanced low-protein diet in chronic renal failure. JAMA 202: 477, 1967
Kopple JD, Sorensen MK, Coburn JW, Gordon A, Rubini ME: Controlled comparison of 20 g and 40 g protein diets in the treatment of chronic uremia. Am J Clin Nutr 21: 553, 1968
Hewlett AW, Gilbert QO, Wickett AD: The toxic effects of urea on normal individuals. Arch Int Med 18: 636, 1916
Grollman EF, Grollman A: Toxicity of urea and its role in the pathogenesis of uremia. J. Clin Invest 38: 749, 1959
Wineman RJ, Sargent JA, Piercy L: The dietitian’s role in quantitative studies of dialysis therapy. J Am Diet Assoc 1978
Sargent JA, Gotch FA: The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int 1 (suppl): S35, 1975
Gotch FA, Sargent JA, Keen ML, Lee M: Individualized, quantified dialysis therapy of uremia. Proc Clin Dial Transpl Forum 4: 27, 1974
Gotch FA, Farrell PC, Sargent JA: Theoretical considerations on molecular transport in dialysis and sorbent therapy for uremia. J Dialysis 1: 105, 1976
Dombeck DH, Klein E, Wendt RP: Evaluation of two pool model for predicting serum creatinine levels during intra and interdialytic periods. Trans Am Soc Artif Intern Organs 21: 117, 1975
Sanfelippo ML, Hall DA, Walker WE, Swenson RS: Quantitative evaluation of hemodialysis therapy using a simple mathematical model and a programmable pocket calculator. Trans Am Soc Artif Intern Organs 21: 125, 1975
Katz MA, Hull AR: Transcellular creatinine disequilibrium and its significance in hemodialysis. Nephron 12: 171, 1974
Bleiler RE, Schedl HP: Creatinine excretion: variability and relationships to diet and body size. J Lab Clin Med 59: 945, 1962
Walser M: The conservative management of the uremic patient. In The Kidney, edited by Brenner BM, Rector FC Jr, Philadelphia, WB Saunders Company, 1976, p 1618
Gotch FA, Sargent JA, Keen ML, Lam M, Prowitt M, Grady M, Schoenfeld P, Borah M, Wolfson M, Piercy L, Leddy E, Humphreys M: The solute kinetics of intermittent dialysis therapy. Second Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1976, p 40 (unpublished)
Swan RC, Pitts RF: Neutralization of infused acid by nephrectomized dogs. J Clin Invest 34: 205, 1955
Gotch FA, Borah M, Keen M, Sargent J, Schoenfeld P, Ayus C, Humphreys M: The solute kinetics of intermittent dialysis therapy (IDT). Proc 10th Annual Contractors Conf Artif Kidney - Chronic Uremia Program NIAMDD 1977, p 104
Graefe U, Milutinovich J, Follette W, Vizzo J, Scribner BH: Effect of high efficiency dialysis on acid-base balance and patient “well being”. Am Soc Nephrol (Abstracts) 9: 31, 1976
Mion CM, Hegstrom RM, Boen ST, Scribner BH: Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis. Trans Am Soc Artif Intern Organs 10: 110, 1964
Mahler HR, Cordes EH: Biological Chemistry, New York, Harper and Row, 1971, p 595
Schwartz WB, Jenson RL, Relman SA: The disposition of acid administered to sodium-depleted subjects: the renal response and the role of the whole body buffers. J Clin Invest 33: 587, 1954
Schwartz WB, Orning KJ, Porter R: The internal distribution of hydrogen ions with varying degrees of metabolic acidosis. J Clin Invest 36: 373, 1957
Gotch FA, Borah MF, Keen ML, Lam MA, Prowitt MH, Sargent JA: The solute kinetics of intermittent dialysis therapy. Third Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1977, p 48 (unpublished)
Garella S, Dana CL, Chazan JA: Severity of metabolic acidosis as a determinant of bicarbonate requirements. N Engl J Med 289: 121, 1973
Weiner MW: The role of acetate in dialysate for hemodialysis. An investigation using biochemical and radio-spirometric techniques. First Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1976, p 108 (unpublished)
Krebs HA: The biochemical lesion in ketosis. Arch Intern Med 107: 119, 1961
Lundquist F: Production and utilization of free acetate in man. Nature 193: 579, 1962
Sargent JA: The role of acetate in acid-base correction during hemodialysis treatment. Doctoral Dissertation University of California, Berkeley, 1976
Burzynski SR: Biologically active peptides in human urine: I. Isolation of a group of medium size peptides. Physiol Chem Physics 5: 437, 1973
Shinaberger JH, Miller JH, Rosenblatt MG, Gardner PW, Carpenter GW, Martin FE: Clinical studies of “low flow” dialysis with membranes highly permeable to middle weight molecules. Trans Am Soc Artif Intern Organs 18: 82, 1972
Rattazzi T, Wathen R, Comty C, Raij L, Leonard A, Shapiro F: The comparison of low flow (QD 200) to regular flow (QD 500) dialysis. Trans Am Soc Artif Intern Organs 20: 402, 1974
Scribner BH, Babb AL: Evidence for toxins of middle molecular weight. Kidney Int 7 (suppl): S349, 1975
Ginn HE, Teschan PE, Walker PJ, Bourne JR, Macalyne F, Ward JW, McLain LW, Johnson HB, Hamel B; Neurotoxicity in uremia. Kidney Int 1 (suppl): S357, 1975
Tenckhoff H, Curtis FK: Experience with maintenance peritoneal dialysis in the home. Trans Am Soc Artif Intern Organs 16: 90, 1970
Bell RL, Curtis FK, Babb AL: Analog simulation of the patient — artificial kidney system. Trans Am Soc Artif Intern Organs 11: 183, 1965
Popovich RP: Physiological transport parameters in patients in peritoneal and hemodialysis. First Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1974 (unpublished)
Gotch FA, Sargent JA, Peters JH: Studies on the molecular etiology of uremia. Kidney Int 7 (suppl): S276, 1975
Henderson LW, Stone RA, Ford CA, Lysaght MJ: Blood pressure control with hemodiafiltration. Proc 10th Annual Contractors’ Conf Artif Kidney — Chronic Uremia Program NIAMDD 1977, p 110 (in press)
Funck-Brentano JL, Man NK, Sausse A, Cueille G, Zingraff J, Drueke T, Jungers P, Billon JP: Neuropathy and “middle” molecule toxins. Kidney Int 1 (suppl): S352, 1975
Gulyassy PF, Peters JH, Lin SC, Ryan PM: Hemodialysis and plasma amino acid composition in chronic renal failure. Am J Clin Nutr 21: 565, 1968
Sargent JA, Gotch FA, Borah MF, Piercy L, Spinozzi N, Schoenfeld PY, Humphreys MH: Urea kinetics: A guide to nutrition management of renal failure. Am J Clin Nutr 1978
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Martinus Nijhoff Publishers bv, The Hague
About this chapter
Cite this chapter
Sargent, J.A., Gotch, F.A. (1979). Principles and Biophysics of Dialysis. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9327-3_3
Download citation
DOI: https://doi.org/10.1007/978-94-009-9327-3_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-247-2227-3
Online ISBN: 978-94-009-9327-3
eBook Packages: Springer Book Archive